Alteration of microvascular permeability in acute kidney injury

Microvascular Research

Volumn 77, Issue 1, 2009, Pages 4-7

  Sutton, Timothy A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute; Endothelium; Kidney; Renal failure

Indexed keywords

ACUTE DISEASE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; ISCHEMIA; KIDNEY INJURY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RENOVASCULAR DISEASE;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; ISCHEMIA; KIDNEY FAILURE, ACUTE; MODELS, BIOLOGICAL; RENAL CIRCULATION;

EID: 59849086542     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.09.004     Document Type: Article

References (69)

1. Adamson R.H. Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx. J. Physiol. 428 (1990) 1-13
2. Alejandro V., et al. Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. J. Clin. Invest. 95 (1995) 820-831
3. Aoki T., et al. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33 (2002) 2711-2717
4. Armao D., et al. Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res. 767 (1997) 259-264
5. Asahi M., et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20 (2000) 1681-1689
6. Asahi M., et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
7. Awad A.S., et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am. J. Physiol. Renal Physiol. 290 (2006) F1516-F1524
8. Axelsen R.A., and Cartwright V.E. Renal function, cortical blood flow and morphometry in ischaemic acute renal failure in the rat. Pathology 11 (1979) 629-640
9. Basile D.P., et al. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 72 (2007) 151-156
10. Basile D.P., et al. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am. J. Physiol. Renal Physiol. 286 (2004) F893-F902
11. Bayati A., et al. Mechanism of erythrocyte trapping in ischaemic acute renal failure. Acta. Physiol. Scand. 138 (1990) 13-23
12. Bonventre J.V., and Weinberg J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J. Am. Soc. Nephrol. 14 (2003) 2199-2210
13. Brodsky S.V., et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am. J. Physiol. Renal Physiol. 282 (2002) F1140-F1149
14. Brun C., et al. Renal blood flow in anuric human subject determined by use of radioactive Krypton 85. Proc. Soc. Exp. Biol. Med. 89 (1955) 687-690
15. Dagher P.C., et al. Newly developed techniques to study and diagnose acute renal failure. J. Am. Soc. Nephrol. 14 (2003) 2188-2198
16. De Greef K.E., et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 60 (2001) 1415-1427
17. Flores J., et al. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J. Clin. Invest. 51 (1972) 118-126
18. Friedewald J.J., and Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 66 (2004) 486-491
19. Fukuda S., et al. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke 35 (2004) 998-1004
20. Goligorsky M.S. Whispers and shouts in the pathogenesis of acute renal ischaemia. Nephrol. Dial Transplant. 20 (2005) 261-266
21. Gupta A., et al. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am. J. Physiol. Renal Physiol. 293 (2007) F245-F254
22. Haller H., et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int. 50 (1996) 473-480
23. Hellberg P.O., et al. Red cell trapping after ischemia and long-term kidney damage. Influence of hematocrit. Kidney Int. 37 (1990) 1240-1247
24. Hellberg P.O., et al. Nephron function in the early phase of ischemic renal failure. Significance of erythrocyte trapping. Kidney Int. 38 (1990) 432-439
25. Hellberg P.O., et al. Peritubular capillary permeability and intravascular RBC aggregation after ischemia: effects of neutrophils. Am. J. Physiol. 258 (1990) F1018-F1025
26. Hollenberg N.K., et al. Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) 47 (1968) 455-474
27. Horbelt M., et al. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 293 (2007) F688-F695
28. Jayle C., et al. Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury. Kidney Int. 69 (2006) 1749-1755
29. Karlberg L., et al. Impaired medullary circulation in postischemic acute renal failure. Acta. Physiol. Scand. 118 (1983) 11-17
30. Kashgarian M., et al. Hemodynamic aspects in development and recovery phases of experimental postischemic acute renal failure. Kidney Int. Suppl. 6 (1976) S160-S168
31. Kelly K.J., et al. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 812-816
32. Kelly K.J., et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. 97 (1996) 1056-1063
33. Kim Y.G., et al. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int. 58 (2000) 2390-2399
34. Liano F., and Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 50 (1996) 811-818
35. Liano F., and Pascual J. Outcomes in acute renal failure. Semin. Nephrol. 18 (1998) 541-550
36. Mason J., et al. Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int. 26 (1984) 283-293
37. Mason J., et al. The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int. 31 (1987) 65-71
38. McVerry B.J., and Garcia J.G. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal 17 (2005) 131-139
39. Mehta R.L., et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 66 (2004) 1613-1621
40. Mizuno S., and Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am. J. Pathol. 166 (2005) 1895-1905
41. Mulivor A.W., and Lipowsky H.H. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1672-H1680
42. Nash K., et al. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39 (2002) 930-936
43. Nemoto T., et al. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int. 60 (2001) 2205-2214
44. Olof P., et al. Red cell trapping and postischemic renal blood flow. Differences between the cortex, outer and inner medulla. Kidney Int. 40 (1991) 625-631
45. Platts S.H., et al. Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H2360-H2367
46. Rabb H., et al. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem. Biophys. Res. Commun. 211 (1995) 67-73
47. Rehm M., et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116 (2007) 1896-1906
48. Rehm M., et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 100 (2004) 1211-1223
49. Reubi R.C., and Vorburger C. Renal hemodynamics in acute renal failure after shock in man. Kidney Int. Suppl. 6 (1976) S137-S143
50. Romanic A.M., et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030
51. Rosenberg G.A., et al. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
52. Schrier R.W., et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest. 114 (2004) 5-14
53. Sehba F.A., et al. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J. Neurosurg. 101 (2004) 633-640
54. Sheehan H.L., and Davis J.C. Renal ischaemia with failed reflow. J. Pathol. Bacteriol. 78 (1959) 105-120
55. Shi H., et al. Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am. J. Physiol. Renal Physiol. 293 (2007) F1512-F1517
56. Singbartl K., et al. Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J. 15 (2001) 2337-2344
57. Soccal P.M., et al. Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation. Am. J. Transplant. 4 (2004) 41-50
58. Soccal P.M., et al. Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation 70 (2000) 998-1005
59. Steinhausen M., et al. High-frequency microcinematographic measurements on peritubular blood flow under control conditions and after temporary ischemia of rat kidneys. Pflugers Arch. 339 (1973) 273-288
60. Summers W.K., and Jamison R.L. The no reflow phenomenon in renal ischemia. Lab. Invest. 25 (1971) 635-643
61. Sutton T.A., et al. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 62 (2002) 1539-1549
62. Sutton T.A., et al. Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury. Am. J. Physiol. Renal Physiol. 288 (2005) F91-F97
63. Sutton T.A., et al. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am. J. Physiol. Renal Physiol. 285 (2003) F191-F198
64. Takada M., et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J. Clin. Invest. 99 (1997) 2682-2690
65. Uchino S., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama 294 (2005) 813-818
66. Vetterlein F., et al. Distribution of capillary blood flow in rat kidney during postischemic renal failure. Am. J. Physiol. 251 (1986) H510-H519
67. Wu X., et al. The role of ICAM-1 in endotoxin-induced acute renal failure. Am. J. Physiol. Renal Physiol. 293 (2007) F1262-F1271
68. Yamamoto T., et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am. J. Physiol. Renal Physiol. 282 (2002) F1150-F1155
69. Yasuda H., et al. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int. 69 (2006) 1535-1542